3 Ovarian Cancer Clinical Trials in St. Petersburg, FL (2026)

Q: How do I join a clinical trial in St. Petersburg?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you.

Recruiting Ovarian Cancer Studies in St. Petersburg

NCT06819007Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy, in participants with huma...

St. Petersburg, FLPHASE3582 participantsDaiichi Sankyo

View Study Details

NCT07059845Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpose of this study is to assess the adverse events and change in disease...

St. Petersburg, FLPHASE2400 participantsAbbVie

View Study Details

NCT05281471Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active...

St. Petersburg, FLPHASE3186 participantsGenelux Corporation

View Study Details

About Ovarian Cancer Clinical Trials in St. Petersburg

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 3 ovarian cancer clinical trials recruiting participants in St. Petersburg, FL. These studies are seeking a combined 1,168 participants. Research is being sponsored by Daiichi Sankyo, AbbVie, Genelux Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in St. Petersburg — FAQ

Are there ovarian cancer clinical trials in St. Petersburg?

Yes, there are 3 ovarian cancer clinical trials currently recruiting in St. Petersburg, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St. Petersburg?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you about next steps.

Are clinical trials in St. Petersburg free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St. Petersburg studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 3 active trials in St. Petersburg are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 22, 2026 from ClinicalTrials.gov